Growing community of inventors

Rockwall, TX, United States of America

Raphael Schiffmann

Average Co-Inventor Count = 2.88

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 103

Raphael SchiffmannFanny Mochel (4 patents)Raphael SchiffmannLawrence Sweetman (2 patents)Raphael SchiffmannSabrina Forni (2 patents)Raphael SchiffmannDavid F Moore (1 patent)Raphael SchiffmannXingli Meng (1 patent)Raphael SchiffmannJinsong Shen (1 patent)Raphael SchiffmannTeodoro G Bottiglieri (1 patent)Raphael SchiffmannErland Arning (1 patent)Raphael SchiffmannFanny Mochel (0 patent)Raphael SchiffmannFanny Mochel (1 patent)Raphael SchiffmannRaphael Schiffmann (6 patents)Fanny MochelFanny Mochel (7 patents)Lawrence SweetmanLawrence Sweetman (2 patents)Sabrina ForniSabrina Forni (2 patents)David F MooreDavid F Moore (3 patents)Xingli MengXingli Meng (1 patent)Jinsong ShenJinsong Shen (1 patent)Teodoro G BottiglieriTeodoro G Bottiglieri (1 patent)Erland ArningErland Arning (1 patent)Fanny MochelFanny Mochel (0 patent)Fanny MochelFanny Mochel (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Baylor Research Institute (5 from 93 patents)

2. National Institute of Health and Medical Research (2 from 2 patents)

3. Other (1 from 832,912 patents)


6 patents:

1. 10111848 - Triheptanoin for the treatment of glucose transport 1 deficiency

2. 9750732 - Urinary triaosylceramide (Gb3) as a marker of cardiac disease

3. 9468229 - Triheptanoin for the treatment of glucose transport 1 deficiency

4. 9155765 - Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)

5. 9066939 - Urinary triaosylceramide (GB3) as a marker of cardiac disease

6. 8410101 - Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/13/2026
Loading…